Suven Life Sciences Limited SUVEN

Latest filings

• General25 12 Nov, 11:44 · NSE
  A press release dated November 12, 2026, titled "Suven Life Sciences to Present Seven Scientific Posters Highlighting Its CNS Drug Discovery and Development Pipeline at Neuroscience 2026 (SfN), Washington DC, USA".
• General25 12 Nov, 11:44 · BSE
  Please find enclosed News Release of our Company
• Routine15 6 Nov, 16:21 · NSE
  Monitoring Agency Report
• Routine15 6 Nov, 13:13 · BSE
  Newspaper publication on Un-audited financial results
• Results73 5 Nov, 13:29 · NSE
  , the financial results for the period ended September 30, 2026.
• Board meeting40 29 Oct, 15:55 · BSE
  Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited financial results ....
• Routine15 23 Oct, 15:08 · BSE
  Special Window for Re-lodgment of transfer requests of Physical shares
• Routine15 7 Oct, 14:31 · BSE
  Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
• Routine15 28 Sept, 14:17 · BSE
  Closure of Trading Window
• General25 3 Sept, 11:56 · BSE
  Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Shown 15 minutes after publication. Real time with Pro.